Integra Lifesciences Holdings Corp
NASDAQ:IART

Watchlist Manager
Integra Lifesciences Holdings Corp Logo
Integra Lifesciences Holdings Corp
NASDAQ:IART
Watchlist
Price: 9.65 USD -2.43% Market Closed
Market Cap: $751.6m

Balance Sheet

Balance Sheet Decomposition
Integra Lifesciences Holdings Corp

Balance Sheet
Integra Lifesciences Holdings Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
44
26
70
47
23
57
184
72
129
101
97
121
72
48
102
175
139
199
470
513
457
276
246
235
Cash Equivalents
44
26
70
47
23
57
184
72
129
101
97
121
72
48
102
175
139
199
470
513
457
276
246
235
Short-Term Investments
55
83
31
80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33
27
29
Total Receivables
19
29
47
49
85
104
112
103
106
118
115
118
110
132
148
252
266
275
233
243
274
259
272
279
Accounts Receivables
19
29
47
49
85
104
112
103
106
118
115
118
110
132
148
252
266
275
233
243
274
259
272
279
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
29
41
56
68
94
145
146
140
147
171
172
207
189
211
217
296
280
316
310
317
325
390
429
493
Other Current Assets
6
13
13
22
20
35
55
50
63
62
69
76
158
47
28
99
90
68
224
80
107
100
107
124
Total Current Assets
152
192
216
266
222
340
497
365
445
452
453
521
529
439
495
822
775
858
1 237
1 154
1 162
1 058
1 082
1 160
PP&E Net
17
20
26
28
43
62
76
84
100
131
178
200
194
205
222
269
300
432
371
396
460
496
550
585
PP&E Gross
17
20
26
28
43
62
76
84
100
131
178
0
194
0
222
269
300
432
371
396
460
496
550
585
Accumulated Depreciation
16
18
23
27
38
47
72
91
111
121
139
0
148
0
191
220
255
285
283
315
330
367
397
444
Intangible Assets
23
52
60
65
180
196
226
211
195
237
212
197
413
604
561
1 160
1 080
1 032
989
1 146
1 127
1 068
1 208
1 135
Goodwill
22
27
39
68
162
207
212
262
262
293
294
250
364
512
511
938
927
954
932
1 014
1 039
1 055
1 097
615
Long-Term Investments
34
98
95
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
27
24
21
6
7
13
15
18
18
30
26
24
88
14
19
22
27
27
85
73
103
104
101
108
Other Assets
22
27
39
68
162
207
212
262
262
293
294
250
364
512
511
938
927
954
932
1 014
1 039
1 055
1 097
615
Total Assets
275
N/A
413
+50%
457
+11%
448
-2%
614
+37%
818
+33%
1 026
+25%
940
-8%
1 019
+8%
1 144
+12%
1 164
+2%
1 192
+2%
1 587
+33%
1 774
+12%
1 808
+2%
3 211
+78%
3 108
-3%
3 303
+6%
3 615
+9%
3 782
+5%
3 890
+3%
3 782
-3%
4 037
+7%
3 602
-11%
Liabilities
Accounts Payable
4
8
10
9
20
23
23
25
28
28
37
51
29
35
29
94
76
113
55
62
102
92
83
96
Accrued Liabilities
9
12
13
22
30
46
49
51
61
70
65
63
74
84
88
161
160
168
183
228
173
192
222
219
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
220
120
100
77
108
0
0
0
4
14
0
60
23
45
146
45
38
15
607
127
Other Current Liabilities
9
1
1
1
4
3
3
4
4
5
5
6
20
6
7
34
4
5
17
5
7
9
10
15
Total Current Liabilities
22
21
24
31
274
192
175
157
202
102
107
119
126
139
124
349
263
331
401
340
321
307
922
456
Long-Term Debt
0
119
119
118
1
330
460
309
295
532
520
392
626
700
665
1 781
1 332
1 303
1 408
1 501
1 405
1 485
1 196
1 730
Deferred Income Tax
0
0
0
3
31
16
0
9
11
6
5
2
100
155
149
65
58
37
16
46
63
35
61
6
Other Liabilities
5
4
6
6
12
20
20
20
12
12
14
13
30
29
31
54
80
216
275
211
296
367
313
367
Total Liabilities
27
N/A
144
+431%
149
+3%
159
+7%
318
+100%
558
+76%
654
+17%
495
-24%
519
+5%
652
+25%
646
-1%
526
-19%
883
+68%
1 023
+16%
968
-5%
2 249
+132%
1 732
-23%
1 887
+9%
2 100
+11%
2 098
0%
2 085
-1%
2 194
+5%
2 492
+14%
2 559
+3%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
Retained Earnings
44
18
0
37
66
98
116
167
233
261
302
281
315
146
220
285
348
399
532
699
879
947
940
423
Additional Paid In Capital
292
287
321
333
367
395
503
521
552
608
587
751
780
1 020
799
822
1 193
1 214
1 291
1 265
1 277
1 302
1 323
1 338
Unrealized Security Profit/Loss
1
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
2
5
20
76
146
252
252
252
284
367
367
367
367
367
123
122
121
120
235
234
363
647
691
689
Other Equity
1
4
8
4
8
19
5
9
2
9
5
1
24
48
57
24
45
76
74
45
10
15
28
30
Total Equity
248
N/A
269
+8%
308
+15%
290
-6%
296
+2%
260
-12%
372
+43%
445
+20%
500
+12%
493
-1%
518
+5%
666
+29%
704
+6%
751
+7%
840
+12%
962
+15%
1 376
+43%
1 417
+3%
1 515
+7%
1 685
+11%
1 804
+7%
1 588
-12%
1 545
-3%
1 043
-32%
Total Liabilities & Equity
275
N/A
413
+50%
457
+11%
448
-2%
614
+37%
818
+33%
1 026
+25%
940
-8%
1 019
+8%
1 144
+12%
1 164
+2%
1 192
+2%
1 587
+33%
1 774
+12%
1 808
+2%
3 211
+78%
3 108
-3%
3 303
+6%
3 615
+9%
3 782
+5%
3 890
+3%
3 782
-3%
4 037
+7%
3 602
-11%
Shares Outstanding
Common Shares Outstanding
54
57
57
55
55
52
56
57
57
54
56
64
66
74
75
78
85
86
84
85
84
78
77
78
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett